Covaxin

Bharat Biotech credited ICMR, NIV as Covaxin co-inventors after missing them initially: Modi government

Initially, when Bharat Biotech filed the patent application, it bore only its name in the application. As soon as the government and ICMR came to know about it, 'we questioned them' as the co-ownership, co-inventor names were not there, Union health minister J P Nadda said.

02 August 2024, 10:39 IST

Bharat Biotech credited ICMR, NIV as Covaxin co-inventors after missing them initially: Modi government

02 August 2024, 10:39 IST

ICMR junks BHU study that over 30% Covaxin takers faced adverse effects

The study, with an acknowledgement to the council, claimed that over 30 per cent people who took the jab encountered adverse events including stroke, Guillain-Barre syndrome, a neurological disorder and upper-respiratory problems.

20 May 2024, 06:18 IST

'Not associated with poorly designed study', ICMR junks BHU claim over 30% Covaxin takers faced adverse effects

ICMR junks BHU study that over 30% Covaxin takers faced adverse effects

20 May 2024, 06:18 IST

One-third of Covaxin takers reported adverse effects: Study

Nearly 50 per cent of 926 study participants in the study complained of infections during the follow-up period.

16 May 2024, 12:58 IST

Over 30% Covaxin takers reported adverse events, claims BHU study

One-third of Covaxin takers reported adverse effects: Study

16 May 2024, 12:58 IST

Covaxin developed with single-minded focus on safety first: Bharat Biotech

The vaccine was evaluated in more than 27,000 subjects as part of its licensure process, Bharat Biotech stated.

02 May 2024, 17:04 IST

Covaxin developed with single-minded focus on safety first: Bharat Biotech

02 May 2024, 17:04 IST

No link between Covid vaccines used in India and heart attack risk, reveals study

The research, published recently in the journal 'PLOS One', determined the impact of Covid-19 vaccination on mortality following acute myocardial infarction (AMI) or heart attack.

04 September 2023, 12:14 IST

No link between Covid vaccines used in India and heart attack risk, reveals study

04 September 2023, 12:14 IST

IIT making Covid jab with low risk of blood clotting

They said the 'next-generation' vaccine is currently in the animal trials phase

16 February 2023, 16:28 IST

IIT Delhi developing Covid vaccine which will minimise chances of blood clotting: Officials

IIT making Covid jab with low risk of blood clotting

16 February 2023, 16:28 IST

Covaxin approval not due to political pressure: Govt

The ministry said CDSCO followed a scientific approach and prescribed norms in approving Covid vaccines for emergency use authorisation

17 November 2022, 15:17 IST

Government junks claims of Covaxin approval due to political pressure

Covaxin approval not due to political pressure: Govt

17 November 2022, 15:17 IST

Japan approves Covaxin booster dose for travellers

In April this year, the Japanese government had announced including Covaxin in its list of recognised vaccines

05 August 2022, 17:12 IST

Japan has approved Covaxin booster dose for travellers: Bharat Biotech

Japan approves Covaxin booster dose for travellers

05 August 2022, 17:12 IST

Covaxin booster works against emerging variants: Study

The study was conducted in 184 subjects, who received either a Covaxin booster dose or a placebo, six months after the primary series of two doses

20 July 2022, 14:42 IST

Covaxin booster effective against emerging Covid-19 variants: Study

Covaxin booster works against emerging variants: Study

20 July 2022, 14:42 IST

NTAGI may consider Corbevax as heterologous booster vax

DCGI on June 4 approved Corbevax as a precaution dose for those aged 18 and above

27 June 2022, 15:53 IST

NTAGI likely to consider Corbevax as booster for those vaccinated with Covishield, Covaxin

NTAGI may consider Corbevax as heterologous booster vax

27 June 2022, 15:53 IST